ABT Overview
Upcoming Projects (ABT)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ABT)
-
A Second Look: Discussing the different aortic heart valves from Edwards Lifesciences, Abbott Laboratories, and Medtronic
Tickers: EW, ABT, MDT, BSX
Executed On: Aug 29, 2023 at 04:30 PM EDT -
Discussing the different aortic heart valves from Edwards Lifesciences, Abbott Laboratories, and Medtronic
Tickers: EW, ABT, MDT
Executed On: Aug 24, 2023 at 08:00 AM EDT -
A Second Opinion: Reviewing the use of Mapping Catheters for Cardiac Arrhythmia procedures with a focus on the newly approved Optrell Catheter from Johnson & Johnson
Tickers: JNJ, ABT, MDT
Executed On: Aug 10, 2023 at 12:30 PM EDT -
Reviewing the use of Mapping Catheters for Cardiac Arrhythmia procedures with a focus on the newly approved Optrell Catheter from Johnson & Johnson
Tickers: JNJ, ABT, MDT
Executed On: Aug 03, 2023 at 05:00 PM EDT -
Discussing implantable Continuous Glucose Monitors (CGMs) for patients with diabetes with a focus on Senseonics' Eversense CGM data
Tickers: SENS, ABT, DXCM, MDT
Executed On: Jul 26, 2023 at 01:00 PM EDT -
Quarterly Survey: Bradycardia and Implantable Pacemakers July 2023
Tickers: MDT, ABT, BSX
Executed On: Jul 25, 2023 at 06:00 PM EDT -
A Second Opinion: Reviewing the FDA approval of Abbott's AVEIR system, the first Dual Chamber Leadless Pacemaker
Tickers: ABT, MDT, BSX, BIOTRONIK
Executed On: Jul 21, 2023 at 12:00 PM EDT -
Reviewing the FDA approval of Abbott's AVEIR system, the first Dual Chamber Leadless Pacemaker
Tickers: ABT, MDT, BSX, BIOTRONIK
Executed On: Jul 20, 2023 at 06:00 PM EDT -
A Second Look: Discussing the potential use of Pulsed Field Ablation devices for the treatment of patients with Atrial Fibrillation.
Tickers: MDT, BSX, ABT, JNJ
Executed On: Jul 14, 2023 at 09:00 AM EDT -
A Second Opinion: Looking at the potential of Know Labs Non-Invasive Continuous Glucose Monitor
Tickers: KNWN, MDT, DXCM, ABT
Executed On: Jun 29, 2023 at 11:00 AM EDT -
Discussing the potential use of Pulsed Field Ablation devices for the treatment of patients with Atrial Fibrillation.
Tickers: BSX, MDT, ABT, JNJ
Executed On: Jun 27, 2023 at 12:00 PM EDT -
Looking at the potential of Know Labs Non-Invasive Continuous Glucose Monitor
Tickers: KNWN, MDT, DXCM, ABT
Executed On: Jun 22, 2023 at 05:15 PM EDT -
A Second View: Gaining insight into the newly approved iLet Bionic Pancreas Insulin Pump for Type 1 Diabetes
Tickers: BETA BIONICS, TNDM, PODD, ABT, MDT
Executed On: Jun 21, 2023 at 06:00 PM EDT -
Gaining insight into the newly approved iLet Bionic Pancreas insulin pump for type 1 diabetes
Tickers: BETA BIONICS, TNDM, PODD, ABT, MDT
Executed On: Jun 15, 2023 at 10:00 AM EDT -
A Second Opinion: Discussing the potential of Abbott's Proclaim XR SCS system which was recently approved for the treatment of diabetic peripheral neuropathy.
Ticker: ABT
Executed On: May 19, 2023 at 10:00 AM EDT -
Discussing the potential of Abbott's Proclaim XR SCS system which was recently approved for the treatment of diabetic peripheral neuropathy.
Ticker: ABT
Executed On: May 08, 2023 at 04:00 PM EDT -
A second opinion: Examining the benefits of Abbott's TriClip device compared to medical therapy for tricuspid regurgitation
Tickers: ABT, EW
Executed On: May 08, 2023 at 09:00 AM EDT -
A Second Opinion: Understanding the future role of Deep Brain Stimulation systems for the treatment of severe depression
Ticker: ABT
Executed On: May 01, 2023 at 12:00 PM EDT -
Understanding the future role of Deep Brain Stimulation systems for the treatment of severe depression
Ticker: ABT
Executed On: Apr 28, 2023 at 11:00 AM EDT -
Examining the benefits of Abbott's TriClip device compared to medical therapy for tricuspid regurgitation
Tickers: ABT, EW
Executed On: Apr 27, 2023 at 02:00 PM EDT -
Quarterly Survey: Bradycardia and Implantable Pacemakers April 2023
Tickers: MDT, ABT, BSX
Executed On: Apr 11, 2023 at 11:34 AM EDT -
A Second View: Discussing the 5-Year COAPT Trial Data on Abbott's MitraClip Mitral Regurgitation device, released at ACC 2023
Ticker: ABT
Executed On: Mar 27, 2023 at 08:30 AM EDT -
Discussing the 5-Year COAPT Trial Data on Abbott's MitraClip Mitral Regurgitation device, released at ACC 2023
Ticker: ABT
Executed On: Mar 10, 2023 at 02:30 PM EST -
Quarterly Survey: Bradycardia and Implantable Pacemakers February 2023
Tickers: MDT, ABT, BSX
Executed On: Feb 07, 2023 at 02:06 PM EST
Expired Projects (ABT)
-
Evaluating the Market Potential of Hua Medicine's HMS5552 in Type II Diabetes Ahead of Mid-Year Phase II Readout. Does the drug have potential to derail the success of major players in the space?
Tickers: HUA MEDICINE, ABT, AZN, NVS, NVO, MRK, SNY, GSK, Lupin Pharmaceuticals, RHHBY
Execute By: May 11, 2016
Upcoming & Overdue Catalysts (ABT)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ABT)
-
FDA Approves Abbott's (ABT) Assurity MRI Pacemaker and Tendril MRI Pacing Lead
Ticker: ABT
Occurred on: Feb 01, 2017 -
Abbott (ABT) Announces Launch of Proclaim DRG Neurostimulation System in Europe for Patients with Chronic Neuropathic Pain
Ticker: ABT
Occurred on: Jan 18, 2017 -
Abbott (ABT) Files Breach-Of-Contract Against Alere (ALR) in Attempt to Obtain Merger-Related Information
Tickers: ABT, ALR
Occurred on: Nov 03, 2016 -
St. Jude (STJ) Recalls Some Heart Devices After Premature Battery Depletion Leads to Two Deaths
Tickers: STJ, ABT
Occurred on: Oct 11, 2016 -
St. Jude Medical's (STJ) EnSite Precision Cardiac Mapping System and New Sensor Enable Tools Released in Europe
Tickers: ABT, STJ
Occurred on: Oct 05, 2016 -
Abbott's (ABT) Continuous Glucose Monitoring System FreeStyle Libre Pro Approved by FDA
Ticker: ABT
Occurred on: Sep 28, 2016 -
Johnson & Johnson (JNJ) Announces $4.325B Cash Deal to Acquire Abbott's (ABT) Medical Optics Business
Tickers: JNJ, ABT
Occurred on: Sep 16, 2016 -
FDA Approves The Tecnis Symfony Intraocular Lenses, The First And Only Extended Depth Of Focus Lenses for People With Cataracts
Ticker: ABT
Occurred on: Jul 15, 2016 -
FDA Approves Abbott's Absorb Bioresorbable Stent, The Only Fully Disolving Heart Stent
Ticker: ABT
Occurred on: Jul 05, 2016 -
Abbott's FreeStyle Libre continuous glucose monitor enables type 1 diabetics to cut hypoglycemic time 38%
Ticker: ABT
Occurred on: Jun 13, 2016 -
An FDA advisory panel has given unanimous support to a one-of-a-kind dissolving heart stent from Abbott Laboratories
Ticker: ABT
Occurred on: Mar 15, 2016 -
FDA to Vote on Approval of Absorb GT1 Bioresorbable Vascular Scaffold (BVS) March 15
Ticker: ABT
Occurred on: Mar 15, 2016
Strategic Initiatives (ABT)
-
St. Jude (STJ) and Abbott (ABT) Agree to Sell Portion of Vascular Closure and Electrophysiology Businesses to Terumo (TRUMF) for $1.12 Billion in Cash
Tickers: ABT, STJ, TRUMF
Announcement Date: Oct 18, 2016 -
Celgene (CELG) and Agios (AGIO) Ink Collaboration Agreement with Abbott (ABT) to Develop and Commercialize Companion Diagnostic Tests for Certain Leukemia Patients
Tickers: CELG, ABT, AGIO
Announcement Date: Oct 12, 2016 -
Abbott to Acquire St Jude Medical for $25B
Tickers: ABT, STJ
Announcement Date: Apr 28, 2016
